Bioflirt Labs is a next-generation translational biotechnology company dedicated to bridging laboratory technologies with real-world medical applications. The company focuses on the research, development, and innovation of extracellular vesicle (EV)- and exosome-based therapies manufactured to high-quality standards for medical and health applications.
We build translational platforms that turn extracellular vesicle science into clinical-grade therapeutics.
Research Laboratories
Manufacturing Systems
Clinical Applications
ASEAN's First CytoFLEX Nano Implementation
Integrated within ISO 13485–aligned quality systems.
Four Technology Pillars
Precision at the Single-Particle Level
Integrated Multi-OMICs Intelligence
Potency & Mechanism Framework
Clinically Aligned Manufacturing Systems
Technology Designed for Clinical Translation
Our platform integrates:
MISEV-aligned characterization principles
Standardized analytical workflows
Quantitative potency evaluation
GMP-ready process development
Product Journey
From Cell Source to Clinical-Grade Exosomes
Source Intelligence
The journey begins with responsible and carefully selected biological sources
Isolation & Purification
Exosomes are isolated using scalable and integrity-preserving systems
Molecular Characterization
Before any functional claim, exosomes undergo rigorous profiling
Functional Potency
Exosomes are evaluated in controlled biological systems
QA/ QC Assurance
Each batch undergoes structured QA/ QC including
Final Readiness
Exosome product move forward to formulation and application development